Nkarta (NKTX) Shares Outstanding (Diluted Average) (2021 - 2026)

Nkarta's quarterly Shares Outstanding (Diluted Average) came in at $74.3 million in Q1 2026, little changed year-on-year from $73.9 million in Q1 2025, and little changed quarter-over-quarter from $74.0 million in Q4 2025.

Nkarta has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $74.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) changed 0.46% year-over-year to $74.3 million; the trailing twelve-month figure through Mar 2026 stood at $74.3 million (changed 0.46% YoY), and the FY2025 full-year result was $74.0 million, up 9.03% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $74.3 million, roughly flat from $74.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $74.3 million in Q1 2026, with the low at $33.0 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $58.6 million, with a median of $50.7 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Diluted Average) soared 50.08% in 2024 and increased 0.46% in 2026.
  • Tracing NKTX's Shares Outstanding (Diluted Average) over 5 years: stood at $43.6 million in 2022, then gained by 12.34% to $49.0 million in 2023, then jumped by 38.46% to $67.9 million in 2024, then climbed by 9.03% to $74.0 million in 2025, then rose by 0.36% to $74.3 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $74.3 million (Q1 2026), $74.0 million (Q4 2025), and $74.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Nkarta 232.80 Mn 232.80 Mn - 74.26 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 74.26 Mn
Dec 31, 2025 73.99 Mn
Sep 30, 2025 73.97 Mn
Jun 30, 2025 73.95 Mn
Mar 31, 2025 73.92 Mn
Dec 31, 2024 67.87 Mn
Sep 30, 2024 73.56 Mn
Jun 30, 2024 73.49 Mn
Mar 31, 2024 50.68 Mn
Dec 31, 2023 49.01 Mn
Sep 30, 2023 49.06 Mn
Jun 30, 2023 48.97 Mn
Mar 31, 2023 48.92 Mn
Dec 31, 2022 43.63 Mn
Sep 30, 2022 48.63 Mn
Jun 30, 2022 38.45 Mn
Mar 31, 2022 32.99 Mn
Dec 31, 2021 32.86 Mn
Sep 30, 2021 32.82 Mn
Jun 30, 2021 32.83 Mn